Indaptus Therapeutics prices USD 24 million private placement of 20,338,974 shares

Reuters2026/09/10 10:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Indaptus Therapeutics entered a stock purchase agreement on Sept. 8, 2026 for a private placement of 20,338,974 shares.
Gross proceeds expected at about $24 million, before expenses.
Pricing set at the Nasdaq Minimum Price, as defined in the agreement, plus USD 0.015 per share.
Net proceeds earmarked for working capital, R&D, general corporate purposes.
Shares sold in an unregistered offering under Section 4(a)(2) and/or Regulation S, subject to transfer restrictions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indaptus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-042037), on September 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Indaptus Therapeutics prices USD 24 million private placement of 20,338,974 shares

You may also like

Crypto prices